Mark Pool - Concepedia

Author

Mark Pool

Also Known As

Christopher W. Seder, David Chesla, Domenico Alvaro, Eugenio Gaudio, George Manikhas, Julia Slotta-Huspenina, Kerstin Junker, Larsson Omberg, M D Pool, M Pool

Publications

35.1K

Citations

H-Index

Concepts

All Affiliations

Rush University Medical Center Harvard University Broad Institute Gynecologic Oncology Group Memorial Sloan Kettering Cancer Center

About

Mark Pool is an author at Rush University Medical Center specializing in medicine, tumor biology, and ovarian cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.1K
2	Cell Biology	2	2	212
3	Engineering	1	1	895
4	Immunology	1	1	11
5	Obstetrics	1	1	116

Mark Pool

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, Cell	2018	425
Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro Xijing He, Mark Pool, Kathleen M. Darcy, Oncogene MedicineGynecologyPolypyrimidine Tract-binding ProteinTumor SuppressorRadiation Oncology	2007	116
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer Xijing He, Ahmet Arslan, Mark Pool, Oncogene OncologyEpithelial Ovarian CancerMedicineApoptosisCancer Cell Biology	2010	96
The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients Mary J. Fidler, Cristina Fhied, Joanna Roder, BMC Cancer	2018	40
CDKN2A (p16) Promoter Hypermethylation Influences the Outcome in Young Lung Cancer Patients Dawn P. Bradly, Paolo Gattuso, Mark Pool, Diagnostic Molecular Pathology	2012	32
Pyrogen reactions to human serum albumin during plasma exchange Mark Pool, Bruce C. McLeod Journal of Clinical Apheresis	1995	24
PCR Production of a Digoxigenin-labeled Probe for the Detection of Human Cytomegalovirus in Tissue Sections Nancy B. Wood, Mira Sheikholeslami, Mark Pool, Diagnostic Molecular Pathology Viral DiagnosticsImmunologyPathologyNucleic Acid Amplification TestPolymerase Chain Reaction	1994	11
Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy Mary J. Fidler, Casey Frankenberger, Richard Seto, Oncotarget	2017	11

Page 1